21 Mar 2017 14:10
21 March 2017
Dechra Pharmaceuticals PLC
(the Company)
Director Shareholding
Dechra Pharmaceuticals PLC has been notified that on 21 March 2017 Anthony Griffin, Executive Director, sold 3,500 ordinary shares in the Company at a price of £16.76 each.
Following this acquisition, Anthony Griffin's beneficial interest in the Company is 64,320 shares (0.069% of the current issued share capital).
The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.
Notification of Dealing Form
1. | Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA") | ||
a) | Name | Anthony Griffin
| |
2. | Reason for the notification | ||
a) | Position/status | Director
| |
b) | Initial notification/ amendment | Initial Notification | |
3. | Details of the Issuer | ||
a) | Name | Dechra Pharmaceuticals PLC | |
b) | LEI code | N/A | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument
Identification code | Ordinary Shares of 1 pence each
ISIN: GB0009633180 | |
b) | Nature of the transaction | Sale of Shares | |
c) | Price(s) and volumes(s) | Price(s) 16.76 | Volume(s) 3,500 |
d) | Aggregated information - Aggregate volume - Price - Total |
3,500
£16.76 £58,660.00 | |
e) | Date of the transaction | 2017.03.21 | |
f) | Place of the transaction | London Stock Exchange | |
For further information, please contact:
Suzana Cross, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.